Premature ejaculation (PE) is the most significant urological dysfunction facing men today. With a reported prevalence rate of up to 30% of men in all age groups, PE represents a large global market opportunity.
The word “delay” translated into Latin is Mora. Morari is an early stage medical device company that is developing the first external device for the treatment of PE. Grounded in basic science and clinical study research, the Morari concept is intended to be a transdermal based product using neuromodulation as a means of inhibiting the nerves of the penis, thereby delaying an ejaculation.
EXTERNAL DEVICE BASED PE TREATMENT USING NEUROMODULATION
Based on basic science research and clinical study data, the Morari concept is a transdermal based product using neuromodulation as a means of inhibiting the nerves of the penis, thereby delaying an ejaculation until the male or female desires to have an ejaculation occur.
“In Western cultures today, as many as 60% of men wish to prolong latency to orgasm and rapid ejaculation is one of the most common complaints from men and couples seeking sex therapy”
Source: Archives of Sexual Behavior; V.24; 1995; p447
Contact us to keep up to date on our progress or to schedule a meeting for more information: